67
Views
49
CrossRef citations to date
0
Altmetric
Original Article

Drug-Phospholipid Interactions: Role in Aminoglycoside Nephrotoxicity

Pages 351-357 | Published online: 07 Jul 2009

References

  • Chung L, Kaloyanides G, McDaniel R, McLaughlin A, McLaughlin S. Interaction of gentamicin and spermine with bilayer membranes containing negatively charged phospholipids. Biochemistry 1985; 24: 442–452
  • Gaver E, Kasianowicz J, Abbott T, McLaughlin S. Binding of neomycin to phosphatidylinositol 4,5-bisphosphate (PIP2. Biochim Biophys Acta 1989; 979: 105–112
  • Au S, Weiner N D, Schacht J. Aminoglycosides preferentially increase permeability in phosphoinositide-containing membranes: A study with carboxyfluorescein in liposomes. Biochim Biophys Acta 1987; 902: 80–86
  • Sastrasinh M, Knauss T C, Weinberg J M, Humes HD. Identification of the aminoglycoside receptor of renal brush border membranes. J Pharmacol Exp Ther 1982; 222: 350–358
  • Schact J. Isolation of the aminoglycoside receptor from guinea pig inner ear tissues and kidneys. Arch Otorhinolaryngol 1979; 224: 129–134
  • Wang B M, Weiner N D, Ganesan M G, Schacht J. Interaction of calcium and neomycin with anionic phospholipid-lecithin liposomes. Biochem Pharmacol 1984; 33: 3787–3791
  • Williams S E, Schacht J. Binding of neomycin and calcium to phospholipids and other anionic compounds. J Antibiot 1986; 39: 457–462
  • Ramsammy L S, Kaloyanides GJ. Effect of gentamicin on the transition temperature and permeability of glycerol of phospha-tidylinositol-containing liposomes. Biochem Pharmacol 1987; 36: 1179–1811
  • Kaloyanides G J, Ramsammy LS. Alterations of biophysical properties of liposomes predict aminoglycoside toxicity: Inhibitory effect of polyaspartic acid. Proceedings of the Fourth International Symposium on Nephrotoxicity, PH Bach, L Delacruz, NJ Gregg, MF Wilks. Dekker, New York 1990; 109–116
  • Ramsammy L S, Kaloyanides GJ. The effect of gentamicin on the biophysical properties of phosphatide acid liposomes is influenced by the 0-C=O group of the lipid. Biochemistry 1988; 27: 8249–8254
  • Brasseur R, Laurent G, Ruysschaert J M, Tulkens P. Interactions of aminoglycoside antibiotics with negatively charged lipid layers. Biochem Pharmacol 1984; 33: 629–637
  • Schacht J, Weiner N D, Lodhi S. Interaction of aminocylitol antibiotics with polyphosphoinositides in mammalian tissues and artificial membranes. Cyclitols and Phosphoinositides, WW Wells, F Eisenberg. Academic Press, New York 1978; 153–169
  • Wang B M, Weiner N D, Takada K, Schacht J. Characterization of aminoglycoside-lipid interactions and development of a refined model for ototoxicity testing. Biochem Pharmacol 1984; 33: 3257–3262
  • Au S, Schacht J, Weiner N. Membrane effects of aminoglycoside antibiotics measures in liposomes containing the fluorescent probe, l-anilino-8-naphthalene sulfonate. Biochim Biophys Acta 1986; 862: 205–210
  • Schacht J. Molecular mechanisms of drug-induced hearing loss. Hearing Res 1986; 22: 297–304
  • Kaloyanides GJ. Aminoglycoside-induced functional and biochemical defects in the renal cortex. Fund Appl Toxicol 1984; 4: 930–943
  • Jospovitz C, Levine R, Lane B, Kaloyanides GJ. Contrasting effects of gentamicin and mercuric chloride on urinary excretion of enzymes and phospholipids in the rat. Lab Invest 1985; 52: 375–386
  • Ibrahim S, van der Auwera P, Meumier F, Tulkens PM. Effect of netilmicin and amikacin on urinary phospholipid excretion in humans. Arch Toxicol 1989; 13: 413–416
  • Josepovitz C, Farruggella T, Levine R, Lane B, Kaloyanides GJ. Effect of netilmicin on the phospholipid composition of subcellular fractions of rat renal cortex. J Pharmacol Exp Ther 1985; 235: 810–819
  • Kozek J C, Mazze R I, Cousins MJ. Nephrotoxicity of gentamicin. Lab Invest 1979; 30: 48–57
  • Giuliano R AA, Paulus G J, Verpooten GA, Pattyn U M, Pollet D E, Nouwen E J, Laurent G, Carlier M B, Maldague P, Tulkens P M, DeBroe ME. Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Kidney Int 1984; 26: 838–847
  • Aubert-Tulkens G, Van Hoof F, Tulkens P. Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts: Quantitative ultrastructural and biochemical study. Lab Invest 1979; 40: 481–491
  • Ramsammy L S, Josepovitz C, Lane B, Kaloyanides GJ. Effect of gentamicin on phospholipid metabolism in cultured rabbit proximal tubular cells. Am J Physiol 1989; 256: C204–C213
  • Carlier M B, Laurent G, Claes P J, Vanderhaeghe H J, Tulkens PM. Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: In vitro comparative studies. Antimicrob Agents Chemother 1983; 23: 440–449
  • Hostetler K Y, Hall LB. Inhibition of kidney lysosomal phospholipases A and D by aminoglycoside antibiotics: Possible mechanism of aminoglycoside toxicity. Proc Natl Acad Sci USA 1982; 79: 1663–1667
  • Laurent C, Carlier M-B, Rollman B, Van Hoof F, Tulkens P. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: In vitro and in vivo studies with gentamicin and amikacin. Biochem Pharmacol 1982; 31: 3861–3870
  • de Broe M E, Paulus G J, Verpooten G A, Roels F, Buyssens N, Weeden R, Van Hoof F, Tulkens PM. Early effects of gentamicin, tobramycin and amikacin on the human. Kidney. Kidney Int 1984; 25: 643–652
  • Mingeot-Laclercq M P, Laurent G, Tulkens PM. Biochemical mechanism of aminoglycoside-induced inhibition of phosphatidylcholine hydrolysis by lysosomal phospholipases. Biochem Pharmacol 1988; 37: 591–599
  • Mingeot-Leclercq M P, Piret J, Brasseur R, Tulkens PM. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition by aminoglycoside antibiotics—I. Biochem Pharmacol 1990; 40: 489–497
  • Ramsammy L, Van Cott C, Kaloyanides GJ. Effect of gentamicin on phosphatidylinositol and phosphatidylcholine hydrolysis by phospholipase Cin vitro. FASEB J 1991; 5: A1406
  • Schwertz D W, Kreisberg J I, Venkatachalam MA. Effects of aminoglycosides on proximal tubule brush border membrane phosphatidylinositol-specific phospholipase C. J Pharmacol Exp Ther 1984; 231: 48–55
  • Laurent G, Kishore B K, Tulkens PM. Aminoglycoside-induced renal phospholipidosis and nephrotoxicity. Biochem Pharmacol 1990; 40: 2383–2392
  • Laurent G, Maldague P, Carlier M D, Tulkens PM. Increased renal DNA synthesis in vivo after administration of low doses of gentamicin to rats. Antimicrob Agents Chemother 1983; 24: 586–593
  • Laurent G, Toubeau G, Heuson-Stiennon J A, Tulkens P, Maldague P. Kidney tissues repair after nephrotoxic injury: Biochemical and morphological characterization. CRC Crit Rev Toxicol 1988; 19: 147–183
  • Toubeau G, Laurent G, Carlier M B, Abid S, Maldague P, Heuson-Stiennon J A, Tulkens PM. Tissue repair in rat kidney cortex after short treatment with aminoglycosides at low doses. Lab Invest 1986; 54: 385–393
  • Josepovitz Levine C. R., Farruggella T, Kaloyanides GJ. Comparative effects of aminoglycosides on renal cortical urinary phospholipids in the rat (42300). Proc Soc Exp Biol Med 1986; 182: 1–5
  • Giurgea-Marion L, Toubeau G, Heuson-Stieraion J A, Tulkens PM. Impairment of lysosome-pinocytic vesicle fusion in rat kidney proximal tubules afer treatment with gentamicinat low doses. Toxicol Appl Pharmacol 1986; 86: 271–285
  • Powell J, Reidenberg MN. In vitro response of rat and human kidney lysosomes to aminoglycosides. Bioohem Pharmacol 1982; 31: 3447–3453
  • Powell J H, Reidenberg MM. Further studies of the response of kidney lysosomes to aminoglycosides and other cations. Biochem Pharmacol 1983; 32: 3213–3220
  • Morin J P, Viotte G, Vanderwalle A, Van Hoof F, Tulkens P, Fillastre JP. Gentamicin-induced nephrotoxicity: A cell biology approach. Kidney Int 1980; 18: 583–590
  • Ngaha E O, Ogunleye JO. Studies on gentamicin-induced labilization of rat kidney lysosomes in vitro. Biochem Pharmacol 1983; 32: 2659–2664
  • Ramsammy L S, Josepovitz C, Kaloyanides GJ. Gentamicin inhibits agonist stimulation of the phosphatidylinositol cascade in primary cultures of rabbit proximal tubular cells and in rat renal cortex. J Pharmacol Exp Ther 1988; 247: 989–996
  • Williams P D, Hottendorf G H, Bennett DB. Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides. J Pharmacol Exp Ther 1986; 237: 919–925
  • Ramsammy L S, Josepovitz C, Lane B P, Kaloyanides GJ. Polyaspartic acid protects agianst gentamicin nephrotoxicity in the rat. J Pharmacol Exp Ther 1989; 250: 149–153
  • Gilbert D N, Wood C A, Kohlhepps S J, Kohnen P W, Houghton D C, Finkbeiner H C, Lindsley J, Bennett WM. Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis 1989; 159: 945–953
  • Ramsammy L S, Josepovitz C, Lane B, Kaloyanides GJ. Pretreatment of rats with polyaspartic acid protects against gentamicin nephrotoxicity. Clin Res 1991; 39: 248A
  • Ramsammy L, Josepovitz C, Lane B, Kaloyanides GJ. Polyaspartic acid inhibits gentamicin-induced perturbations of phospholipid metabolism. Am J Physiol 1990; 258: C1141–C1149
  • Josepovitz C, Pastoriza-Munoz E, Timmerman D, Scott M, Feldman S, Kaloyanides GJ. Inhibition of gentamicin uptake in rat renal cortex in vivo by aminoglycosides and organic polyca-tions. J Pharmacol Exp Ther 1982; 223: 314–321

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.